HilleVax (HLVX) Revenue & Revenue Breakdown
HilleVax Revenue Highlights
00
HilleVax Revenue by Period
HilleVax Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
HilleVax Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $2.86M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | - |
HilleVax Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
STRO | Sutro Biopharma | $153.73M | $25.71M |
TRDA | Entrada Therapeutics | $129.01M | $19.57M |
MOLN | Molecular Partners | $7.04M | $2.74M |
CNTA | Centessa Pharmaceuticals | $6.88M | - |
IPSC | Century Therapeutics | $2.23M | $791.00K |
STTK | Shattuck Labs | $1.66M | $1.61M |
MNOV | MediciNova | $1.00M | - |
OPT | Opthea | $108.41K | $61.27K |
CGEM | Cullinan Oncology | - | - |
CCCC | C4 Therapeutics | - | - |
PHVS | Pharvaris | - | - |
ELYM | Eliem Therapeutics | - | - |
PMVP | PMV Pharmaceuticals | - | - |
MLYS | Mineralys Therapeutics | - | - |
PRDS | Pardes Biosciences | - | - |
VIGL | Vigil Neuroscience | - | - |
HLVX | HilleVax | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
EWTX | Edgewise Therapeutics | - | - |
PEPG | PepGen | - | - |
CSBR | Champions Oncology | - | - |